Standout Papers

Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-n... 2021 2026 2022 2024182
  1. Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trial (2021)
    Shipo Wu, Jianying Huang et al. The Lancet Infectious Diseases

Immediate Impact

1 by Nobel laureates 58 standout
Sub-graph 1 of 23

Citing Papers

Nanotechnology’s frontier in combatting infectious and inflammatory diseases: prevention and treatment
2024 Standout
Induced pluripotent stem cells (iPSCs): molecular mechanisms of induction and applications
2024 Standout
2 intermediate papers

Works of Busen Wang being referenced

Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trial
2021 Standout

Author Peers

Author Last Decade Papers Cites
Busen Wang 247 62 90 84 18 395
Maryam Shafaati 159 22 143 221 35 418
Masanori Hashino 165 24 75 140 24 439
Victoria A. Jenkins 153 58 223 142 20 423
Sitthichai Kanokudom 304 17 35 59 34 369
Raeece Naeem 166 22 126 113 16 423
Catalina Pardo‐Roa 137 92 91 123 17 454
Michael Royals 183 26 101 42 16 412
Joan R. Davies 149 30 221 49 25 432
Hannah M. Rowe 143 57 139 124 16 401
Annelies Aerssens 170 27 141 26 15 338

All Works

Loading papers...

Rankless by CCL
2026